# v3.4

Data released on June 17, 2021

## Related releases
https://www.oncokb.org/news#06172021

## Data Changes
Alteration:
BRAF V600_K601delinsE, Mutation Effect Description Updated
BRAF A598_T599insV Added
BRCA2 R174C, Mutation Effect Description Updated
BRCA2 R174C, Oncogenicity Updated
	 New: Inconclusive
	 Old: Likely
EGFR 729_761del [Exon 19 deletion], Oncogenicity Updated
	 New: Likely
	 Old: Yes
EGFR 762_823ins [Exon 20 insertion], Oncogenicity Updated
EGFR 729_761ins [Exon 19 insertion], Oncogenicity Updated
EGFR R252C, Mutation Effect Description Updated
EGFR R252C, Oncogenicity Updated
	 Old: Likely Neutral
EWSR1 Fusions, Mutation Effect Description Updated
FGFR2 Y375C, Mutation Effect Description Updated
FGFR2 W290_I291delinsC, Mutation Effect Description Updated
FGFR2 C382R, Mutation Effect Description Updated
FGFR2 K525E Deleted
FGFR2 V754I, Mutation Effect Description Updated
FGFR2 V754I Name Changed
	 New: V754I
	 Old: V755I
FGFR2 T729S, Mutation Effect Description Updated
FGFR2 T729S Name Changed
	 New: T729S
	 Old: T730S
FGFR2 I288_E295delinsT, Oncogenicity Updated
	 Old: 
FGFR2 H167_N173del, Oncogenicity Updated
	 New: Yes
FGFR2 F276C, Mutation Effect Description Updated
FGFR2 L617F, Mutation Effect Description Updated
FLT3 Amplification Deleted
H3-3A K28M, Oncogenicity Updated
	 Old: Inconclusive
H3-3A G35R, Oncogenicity Updated
H3-3A G35V, Oncogenicity Updated
KIT X550_splice Added
KRAS G13E Added
KRAS G13V Added
KRAS Q61E Added
KRAS Q61K Added
KRAS G12W Added
KRAS G13R Added
KRAS K117D Added
KRAS A146P Added
KRAS A59T Added
MET 981_1028splice, 963_1010splice [Exon 14 splice mutation], X963_splice, X1006_splice, X1007_splice, X1008_splice, X1009_splice, X1010_splice, 963_1010del [Exon 14 deletion], Oncogenicity Updated
NRAS G12W Added
NRAS G12A Added
NRAS G12F Added
NRAS G12S Added
NRAS Q61E Added
NRAS A59G Added
NRAS A59T Added
NRAS A146V Added
NRAS A146P Added
NRAS K117D Added
NRAS G13E Added
NRAS G13C Added
NRAS G13R Added
PIK3CA 979_1068mis [Exon 20 mutation] Deleted
PIK3CA M1004I, Oncogenicity Updated

Evidence:
ARID1A Truncating Mutations, All Solid Tumors Added
ARID1A Truncating Mutations, All Solid Tumors, Tumor Type Summary Updated
BRAF Oncogenic Mutations, Histiocytosis, Cobimetinib  Updated
BRCA1 Oncogenic Mutations, Ovarian Cancer, Ovary/Fallopian Tube, Peritoneal Serous Carcinoma, Olaparib, Olaparib + Bevacizumab  Updated
BRCA2 Oncogenic Mutations, Ovarian Cancer, Ovary/Fallopian Tube, Peritoneal Serous Carcinoma, Olaparib, Olaparib + Bevacizumab  Updated
EGFR L858R, 729_761del [Exon 19 deletion], Non-Small Cell Lung Cancer, Erlotinib, Erlotinib + Ramucirumab  Updated
ERBB2 Amplification, Esophagogastric Cancer, Tumor Type Summary Updated
ERBB2 Amplification, Esophagogastric Cancer, Pembrolizumab + Trastuzumab + Chemotherapy 1 Added
EZH2 Oncogenic Mutations, Follicular Lymphoma, Tumor Type Summary Updated
EZH2 Oncogenic Mutations, Follicular Lymphoma, Tazemetostat 2 Added
FGFR2 Fusions, Bladder Cancer, Tumor Type Summary Updated
FGFR2 Fusions, Other Tumor Types, Tumor Type Summary Updated
FGFR2 Oncogenic Mutations, All Solid Tumors, Tumor Type Summary Updated
FGFR2 Fusions, Cholangiocarcinoma, Tumor Type Summary Updated
FGFR2 Fusions, Cholangiocarcinoma, Infigratinib 1 Added
FGFR3 S371C, G380R, K650, Bladder Cancer, Erdafitinib  Updated
FLT3 E604_Y958mis, E604_Y958ins, E604_Y958del [Tyrosine kinase domain mutation] Deleted
FLT3 D835, I836, Acute Myeloid Leukemia, Diagnostic Updated
FLT3 D835, I836, Acute Myeloid Leukemia, Diagnostic Summary Updated
HRAS Oncogenic Mutations, Head and Neck Squamous Cell Carcinoma, Tipifarnib  Updated
IDH1 R132C, R132H, R132G, R132S, R132L Added
IDH1 Oncogenic Mutations, Acute Myeloid Leukemia, Tumor Type Summary Updated
IDH1 Oncogenic Mutations, Acute Myeloid Leukemia, Ivosidenib 1 Deleted
IDH1 Oncogenic Mutations, Acute Myeloid Leukemia, Ivosidenib 2 Added
IDH2 Oncogenic Mutations, Acute Myeloid Leukemia, Tumor Type Summary Updated
IDH2 Oncogenic Mutations, Acute Myeloid Leukemia, Enasidenib 1 Deleted
IDH2 R140Q, R140L, R140G, R140W, R172K, R172M, R172G, R172S, R172W Added
IDH2 Oncogenic Mutations, Acute Myeloid Leukemia, Enasidenib 2 Added
KIT K550_V555delinsI, K550_W557del, K550_K558del, K550_G592del, P551_M552del, P551_E554del, P551_V555del, M552_W557del, M552_K558del, Y553_Q556del, Y553_K558del, E554_V559del, E554_I571del, E554_K558del, V555_V559del, V555_L576del, Q556_K558del, W557G, W557R, W557_K558del, W557_V559delinsC, W557_V560del, K558N, K558delinsNP, K558_V559del, K558_E562del, V559A, V559C, V559D, V559G, V559I, V559del, V559_V560del, V559_G565del, V560D, V560E, V560G, V560del, I563_L576del, N564_Y578del, Y568_L576delinsVN, V569_L576del, D572A, P573_D579del, T574insTQLPYD, T574_R588delinsL, L576P, L576del, P577_D579del, P577_W582delinsPYD, Y578C, D579del, W557C, K558_V560del, P551_W557delinsL, P573Q, Y578_D579insEQQLPY, D579_H580insLPCD, Q575_L576dup, Q575_P585dup, V559F, P577_R588dup, Y578_D579dup, D579_H580insFNPTQLPYD, D572_P573dup, X550_splice  (Exon 11 mutations) Name Changed
	 New: K550_V555delinsI, K550_W557del, K550_K558del, K550_G592del, P551_M552del, P551_E554del, P551_V555del, M552_W557del, M552_K558del, Y553_Q556del, Y553_K558del, E554_V559del, E554_I571del, E554_K558del, V555_V559del, V555_L576del, Q556_K558del, W557G, W557R, W557_K558del, W557_V559delinsC, W557_V560del, K558N, K558delinsNP, K558_V559del, K558_E562del, V559A, V559C, V559D, V559G, V559I, V559del, V559_V560del, V559_G565del, V560D, V560E, V560G, V560del, I563_L576del, N564_Y578del, Y568_L576delinsVN, V569_L576del, D572A, P573_D579del, T574insTQLPYD, T574_R588delinsL, L576P, L576del, P577_D579del, P577_W582delinsPYD, Y578C, D579del, W557C, K558_V560del, P551_W557delinsL, P573Q, Y578_D579insEQQLPY, D579_H580insLPCD, Q575_L576dup, Q575_P585dup, V559F, P577_R588dup, Y578_D579dup,D579_H580insFNPTQLPYD, D572_P573dup, X550_splice  (Exon 11 mutations)
	 Old: K550_V555delinsI, K550_W557del, K550_K558del, K550_G592del, P551_M552del, P551_E554del, P551_V555del, M552_W557del, M552_K558del, Y553_Q556del, Y553_K558del, E554_V559del, E554_I571del, E554_K558del, V555_V559del, V555_L576del, Q556_K558del, W557G, W557R, W557_K558del, W557_V559delinsC, W557_V560del, K558N, K558delinsNP, K558_V559del, K558_E562del, V559A, V559C, V559D, V559G, V559I, V559del, V559_V560del, V559_G565del, V560D, V560E, V560G, V560del, I563_L576del, N564_Y578del, Y568_L576delinsVN, V569_L576del, D572A, P573_D579del, T574insTQLPYD, T574_R588delinsL, L576P, L576del, P577_D579del, P577_W582delinsPYD, Y578C, D579del, W557C, K558_V560del, P551_W557delinsL, P573Q, Y578_D579insEQQLPY, D579_H580insLPCD, Q575_L576dup, Q575_P585dup, V559F, P577_R588dup, Y578_D579dup,D579_H580insFNPTQLPYD, D572_P573dup  (Exon 11 mutations)
KRAS Wildtype, Colorectal Cancer, Regorafenib 1 Deleted
KRAS G12C, Other Solid Tumor Types, Tumor Type Summary Updated
KRAS G12C, Colorectal Cancer, Tumor Type Summary Updated
KRAS G12C, Non-Small Cell Lung Cancer, Tumor Type Summary Updated
KRAS G12C, Non-Small Cell Lung Cancer, Sotorasib 1 Added
KRAS G12C, Non-Small Cell Lung Cancer, Sotorasib 3A Deleted
MAP2K2 Oncogenic Mutations, Histiocytosis, Cobimetinib  Updated
MTOR L2427Q, L2209V Name Changed
	 New: L2427Q, L2209V
	 Old: L2427Q, L2209V, L1460P
NRAS Oncogenic Mutations, Melanoma, Binimetinib 2 Added
NRAS Oncogenic Mutations, Melanoma, Binimetinib 2 Deleted
PDGFB COL1A1-PDGFB Fusion, Dermatofibrosarcoma Protuberans, Tumor Type Summary Updated
PDGFRA D842Y, D842_H845del, D842_H845insV, Gastrointestinal Stromal Tumor, Tumor Type Summary Updated
PDGFRA D842V, D842Y, D842_H845del, D842_H845insV Deleted
PDGFRA D842Y, D842_H845del, D842_H845insV, Other Solid Tumor Types, Tumor Type Summary Updated
PDGFRA C814_S852mis [Exon 18 missense mutations], C814_S852del [Exon 18 in-frame deletions], C814_S852ins [Exon 18 in-frame insertions] (Exon 18 mutations) Added
PIK3CA C420R, E542K, E545A, E545D, E545G, E545K, Q546E, Q546R, H1047L, H1047R, H1047Y Added
PIK3CA Oncogenic Mutations, Breast Cancer, Alpelisib + Fulvestrant 2 Updated
PIK3CA Oncogenic Mutations, Breast Cancer, Tumor Type Summary Updated
